Colm Bergin

10.1k total citations · 1 hit paper
154 papers, 3.1k citations indexed

About

Colm Bergin is a scholar working on Infectious Diseases, Epidemiology and Hepatology. According to data from OpenAlex, Colm Bergin has authored 154 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Infectious Diseases, 65 papers in Epidemiology and 32 papers in Hepatology. Recurrent topics in Colm Bergin's work include HIV/AIDS Research and Interventions (33 papers), Hepatitis C virus research (31 papers) and COVID-19 Clinical Research Studies (21 papers). Colm Bergin is often cited by papers focused on HIV/AIDS Research and Interventions (33 papers), Hepatitis C virus research (31 papers) and COVID-19 Clinical Research Studies (21 papers). Colm Bergin collaborates with scholars based in Ireland, United Kingdom and United States. Colm Bergin's co-authors include Liam Townsend, Clíona Ní Cheallaigh, S Clarke, Ciarán Bannan, Ignacio Martín‐Loeches, Niall Conlon, Mary Horgan, Vincent Soriano, Suzanne Norris and Jamie M. O’Sullivan and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Colm Bergin

144 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Persistent Poor Health after COVID-19 Is Not Associated with Respiratory Complications or Initial Disease Severity

2021 185 citations Liam Townsend, Adam H. Dyer et al. profile →

Peers

Countries citing papers authored by Colm Bergin

Since Specialization

Citations

This map shows the geographic impact of Colm Bergin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colm Bergin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colm Bergin more than expected).

Fields of papers citing papers by Colm Bergin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colm Bergin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colm Bergin. The network helps show where Colm Bergin may publish in the future.

Co-authorship network of co-authors of Colm Bergin

This figure shows the co-authorship network connecting the top 25 collaborators of Colm Bergin. A scholar is included among the top collaborators of Colm Bergin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colm Bergin. Colm Bergin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Human Alveolar Macrophages Detect SARS‐CoV‐2 Envelope Protein Through TLR2 and TLR4 and Secrete Cytokines in Response 2025 ·Immunology ·(unknown), (unknown), Finbarr O’Connell, Parthiban Nadarajan, Colm Bergin, Joseph Keane, Mary P. O’Sullivan	1
2	Immune response in vaccinated healthcare workers with frequent COVID-19 infections is characterised by blunted IFNγ and IL-2 responses to SARS-CoV-2 variants 2024 ·Clinical Immunology ·Liam Townsend, Jean Dunne, (unknown), (unknown), (unknown), (unknown), William McCormack, Colm Bergin, Catherine Fleming, Cliona O’Farrelly, Gareth Brady, Niall Conlon	1
3	Episodic disability questionnaire (EDQ) measurement properties among adults living with HIV in Canada, Ireland, United Kingdom, and United States 2024 ·BMC Infectious Diseases ·Kelly K. O’Brien, Kristine M. Erlandson, Darren A. Brown, Soo Chan Carusone, Jaime H. Vera, Colm Bergin, Lisa Avery, Ahmed M. Bayoumi, Steven Hanna, Richard Harding, Patricia Solomon, (unknown), (unknown), (unknown), Marta Boffito, (unknown), (unknown), (unknown), Aileen M. Davis	2
4	Health Care Personnel Workdays Lost and Direct Health Care Salary Costs Incurred due to COVID-19 Infection in the Age of Widespread Vaccine Availability 2024 ·The Journal of Infectious Diseases ·Liam Townsend, Paddy Gillespie, (unknown), (unknown), (unknown), Lorraine Doherty, Lisa Domegan, Niall Conlon, (unknown), Cillian De Gascun, (unknown), Mary T. Keogan, N. Noonan, Cliona O’Farrelly, David Byrne, Colm Bergin, Catherine Fleming	3
5	Endothelial cell activation, Weibel-Palade body secretion, and enhanced angiogenesis in severe COVID-19 2023 ·Research and Practice in Thrombosis and Haemostasis ·Ellie Karampini, Helen Fogarty, (unknown), (unknown), Colm Bergin, Jamie M. O’Sullivan, Mary Byrne, Ignacio Martín‐Loeches, Patrick Mallon, Gerard F. Curley, Siobhán Glavey, Ross Baker, Michelle Lavin, Roger J. S. Preston, Clíona Ní Cheallaigh, Soracha E. Ward, James S. O’Donnell	9
6	Assessing the sensibility and utility of a short-form version of the HIV Disability Questionnaire in clinical practice settings in Canada, Ireland and the USA: a mixed methods study 2022 ·BMJ Open ·Kelly K. O’Brien, Patricia Solomon, Soo Chan Carusone, Kristine M. Erlandson, Colm Bergin, Ahmed M. Bayoumi, Steven Hanna, Richard Harding, Darren A. Brown, Jaime H. Vera, Marta Boffito, (unknown), (unknown), (unknown), (unknown), (unknown), Marilyn Swinton, (unknown), Aileen M. Davis	4
7	Specific human cytomegalovirus signature detected in NK cell metabolic changes post vaccination 2021 ·npj Vaccines ·(unknown), Vanessa Zaiatz-Bittencourt, Ciarán Bannan, Colm Bergin, David K. Finlay, Matthias Hoffmann, Anthony Brown, (unknown), Shokouh Makvandi‐Nejad, (unknown), Stefania Capone, Antonella Folgori, Tomáš Hanke, Eleanor Barnes, Lucy Dorrell, Clair M. Gardiner	3
8	Dynamic Assay for Profiling Anti-SARS-CoV-2 Antibodies and Their ACE2/Spike RBD Neutralization Capacity 2021 ·Viruses ·Thomas Phelan, Jean Dunne, Niall Conlon, Clíona Ní Cheallaigh, W. Mark Abbott, (unknown), Fatima Amanat, Florian Krammer, Mark A. Little, Gerard Hughes, Colm Bergin, Colm Kerr, (unknown), Aideen Long, William McCormack, Gareth Brady	11
9	Prolonged elevation of D‐dimer levels in convalescent COVID‐19 patients is independent of the acute phase response 2021 ·Journal of Thrombosis and Haemostasis ·Liam Townsend, Helen Fogarty, Adam H. Dyer, Ignacio Martín‐Loeches, Ciarán Bannan, Parthiban Nadarajan, Colm Bergin, Cliona O’Farrelly, Niall Conlon, Nollaig M. Bourke, Soracha E. Ward, Mary Byrne, Kevin M. Ryan, Niamh O’Connell, Jamie M. O’Sullivan, Clíona Ní Cheallaigh, James S. O’Donnell	120
10	Acceptability of and symptom findings from an online symptom check-in tool for COVID-19 outpatient follow-up among a predominantly healthcare worker population 2021 ·BMJ Open ·Colm Kerr, (unknown), (unknown), Gerard Hughes, Úna Geary, Mary Paula Colgan, Caitríona Canning, Zenia Martin, Concepta Merry, N. Noonan, Colm Bergin	4
11	Disability and self-care living strategies among adults living with HIV during the COVID-19 pandemic 2021 ·AIDS Research and Therapy ·Kelly K. O’Brien, Ahmed M. Bayoumi, Soo Chan Carusone, Aileen M. Davis, (unknown), Lisa Avery, Patricia Solomon, Kristine M. Erlandson, Colm Bergin, Richard Harding, Darren A. Brown, Jaime H. Vera, Steven Hanna	6
12	High-Cost, High-Need Users of Acute Unscheduled HIV Care: A Cross-Sectional Study 2020 ·Open Forum Infectious Diseases ·(unknown), Colm Bergin, Sarah O’Connell, (unknown), Clíona Ní Cheallaigh	2
13	Opt-out bloodborne virus screening: a cross-sectional observational study in an acute medical unit 2019 ·BMJ Open ·(unknown), (unknown), (unknown), Anne Lyons, (unknown), (unknown), (unknown), Sarah O’Connell, (unknown), (unknown), Colm Bergin, J. Jack Lee, Catherine Fleming, David Gallagher, Helen Tuite	3
14	Telementoring with project ECHO: a pilot study in Europe 2017 ·BMJ Innovations ·Clíona Ní Cheallaigh, Aisling O’Leary, (unknown), (unknown), (unknown), Eamon Keenan, Lisa Robson, (unknown), (unknown), Sanjeev Arora, Colm Bergin, Suzanne Norris	35
15	Usage of unscheduled hospital care by homeless individuals in Dublin, Ireland: a cross-sectional study 2017 ·BMJ Open ·Clíona Ní Cheallaigh, Sarah Cullivan, (unknown), (unknown), (unknown), (unknown), Ricardo Segurado, Austin O’Carroll, Fiona O’Reilly, (unknown), Colm Bergin, Rose Anne Kenny, Declan Byrne	37
16	HPV vaccine acceptability in HIV-infected and HIV negative men who have sex with men (MSM) in Ireland 2016 ·Human Vaccines & Immunotherapeutics ·Corinna Sadlier, (unknown), (unknown), (unknown), (unknown), S Clarke, Orla Sheils, Colm Bergin	20
17	Cerebrospinal Fluid (CSF) Findings of Patients with HIV Associated Neurocognitive Disorders (HAND) (P2.316) 2015 ·Neurology ·(unknown), Pádraic J. Dunne, Brian Lawlor, Janice Redmond, Colin P. Doherty, Derek G. Doherty, Colm Bergin	1
18	Sternoclavicular joint septic arthritis and osteomyelitis caused by Aggregatibacter aphrophilus 2012 ·QJM ·(unknown), Daire O’Shea, Kevin O‘Connell, Brendan Crowley, Colm Bergin	5
19	Human Immunodeficiency Virus Type 1 in Ireland: Phylogenetic Evidence for Risk Group-Specific Subepidemics 2011 ·AIDS Research and Human Retroviruses ·Cillian De Gascun, Allison Waters, (unknown), Jane A. O’Halloran, (unknown), Suzie Coughlan, Colm Bergin, William G. Powderly, William W. Hall	3
20	Implementing a pharmacist-led sequential antimicrobial therapy strategy: a controlled before-and-after study 2011 ·International Journal of Clinical Pharmacy ·(unknown), (unknown), Bernard Silke, Thomas R. Rogers, Colm Bergin	66

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact